A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
Completed
Conditions studied: Allergic Conjunctivitis
In brief
The study was designed to evaluate the pattern of seasonal allergic signs and symptoms consistent with ongoing ocular allergic inflammation during ragweed season. It was hypothesized that a pattern of ongoing ocular allergic inflammation existed in certain subjects.
Key facts
- Study ID
- NCT00982163
- Run by
- ORA, Inc.
- People needed
- 34
- Starts
- 2008-08-01
- Expected to finish
- 2009-09-01
- Last updated by the study team
- 2009-09-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must:
- be willing and able to read, sign, and date the informed consent and HIPAA documents prior to initiation of Visit 1 procedures or exams;
- be at least 18 years of age;
- be willing to avoid disallowed medication, such as anti-allergy therapies
- have a positive history of ocular allergies and a positive skin test reaction to ragweed within the past 24 months;
- have a calculated logMAR visual acuity score using the ETDRS Chart of 0.60 or better in each eye at Visit 1;
You may not qualify if…
- Subjects may not:
- have preauricular lymphadenopathy or any ocular condition that could affect study parameters (particularly, clinically significant blepharitis, follicular conjunctivitis and iritis);
- have had any ocular infection within the last 30 days;
- have a positive diagnosis of moderate to severe dry eye syndrome (i.e., requiring daily use of artificial tears);
- wear contact lenses to each office visit; Note: Subjects will be allowed to use cold compresses.
Where it is running
- ORA, Inc. — North Andover, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.